Use of sulfonamides for the treatment of bovine neonatal diarrhea: clinical and performance parameters

Q3 Veterinary
Rosana Klaus, Laura Valadão Vieira, Adriane Dalla Costa de Matos, A. Barbosa, M. N. Corrêa, R. A. Pereira, E. G. Xavier, C. Brauner, F. D. Del Pino, V. Rabassa
{"title":"Use of sulfonamides for the treatment of bovine neonatal diarrhea: clinical and performance parameters","authors":"Rosana Klaus, Laura Valadão Vieira, Adriane Dalla Costa de Matos, A. Barbosa, M. N. Corrêa, R. A. Pereira, E. G. Xavier, C. Brauner, F. D. Del Pino, V. Rabassa","doi":"10.11606/ISSN.1678-4456.BJVRAS.2021.174336","DOIUrl":null,"url":null,"abstract":"This study was developed to evaluate the clinical, hematological, and performance parameters of calves affected by diarrhea caused by the bacterial enteric pathogen Escherichia coli, treated with three different protocols containing sulfonamides. Fourteen Holstein calves were monitored from birth to 60 days of age, and divided into 3 groups. Group 1 (n=5) animals were treated with 80 g of Kaopek®, Ibasa, Brazil, administered orally (BM), dissolved in 160 ml of water every 24 h; Group 2 (n=4) received IM sulfadiazine and trimethoprim (Ibatrim®, Ibasa, Brazil), and Group 3 (n=5) animals were treated with 80 g of Kaopek®, Ibasa, Brazil, which is made up of 16 g of phthalylsulfathiazole, associated with 2.28 g neomycin sulfate, 1.6 g of pectin, and 80 g of kaolin, dissolved in 160 ml of water and administered every 24 h by mouth, in addition to sulfadiazine and trimethoprim (Ibatrim®, Ibasa, Brazil), at a daily dose of 16 mg/kg live weight, through IM injection. During the study, the animals were clinically evaluated, and once they were diagnosed with diarrhea, feces samples were collected to identify the bacterial enteric pathogen, antibiogram, polymerase chain reaction (PCR), and coproparasitological exams. Blood samples were collected to evaluate the hematological profile, and the performance profile was monitored weekly. In the clinical examination, all calves presented a reduction in body temperature (<39.2°C) and some improvement in hydration after treatment (p=0,31). However, group 2 had a better concentration of lymphocytes and TP concerning the other animals, as well as better performance. Besides, E.coli was detected in 100% of feces samples. Thus, the therapeutic protocols with sulfonamides used to treat bovine neonatal diarrhea were effective in the clinical improvement of the animals. Nonetheless, the protocol with systemic therapy using sulfadiazine and trimethoprim (Ibatrim®, Ibasa, Brazil) intramuscularly, provided better performance, with better weight gain, and body development of the animals.","PeriodicalId":9119,"journal":{"name":"Brazilian Journal of Veterinary Research and Animal Science","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-04-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Brazilian Journal of Veterinary Research and Animal Science","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.11606/ISSN.1678-4456.BJVRAS.2021.174336","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Veterinary","Score":null,"Total":0}
引用次数: 2

Abstract

This study was developed to evaluate the clinical, hematological, and performance parameters of calves affected by diarrhea caused by the bacterial enteric pathogen Escherichia coli, treated with three different protocols containing sulfonamides. Fourteen Holstein calves were monitored from birth to 60 days of age, and divided into 3 groups. Group 1 (n=5) animals were treated with 80 g of Kaopek®, Ibasa, Brazil, administered orally (BM), dissolved in 160 ml of water every 24 h; Group 2 (n=4) received IM sulfadiazine and trimethoprim (Ibatrim®, Ibasa, Brazil), and Group 3 (n=5) animals were treated with 80 g of Kaopek®, Ibasa, Brazil, which is made up of 16 g of phthalylsulfathiazole, associated with 2.28 g neomycin sulfate, 1.6 g of pectin, and 80 g of kaolin, dissolved in 160 ml of water and administered every 24 h by mouth, in addition to sulfadiazine and trimethoprim (Ibatrim®, Ibasa, Brazil), at a daily dose of 16 mg/kg live weight, through IM injection. During the study, the animals were clinically evaluated, and once they were diagnosed with diarrhea, feces samples were collected to identify the bacterial enteric pathogen, antibiogram, polymerase chain reaction (PCR), and coproparasitological exams. Blood samples were collected to evaluate the hematological profile, and the performance profile was monitored weekly. In the clinical examination, all calves presented a reduction in body temperature (<39.2°C) and some improvement in hydration after treatment (p=0,31). However, group 2 had a better concentration of lymphocytes and TP concerning the other animals, as well as better performance. Besides, E.coli was detected in 100% of feces samples. Thus, the therapeutic protocols with sulfonamides used to treat bovine neonatal diarrhea were effective in the clinical improvement of the animals. Nonetheless, the protocol with systemic therapy using sulfadiazine and trimethoprim (Ibatrim®, Ibasa, Brazil) intramuscularly, provided better performance, with better weight gain, and body development of the animals.
磺酰胺类药物治疗牛新生儿腹泻的临床和性能参数
本研究旨在评估受细菌性肠道病原体大肠杆菌引起的腹泻影响的小牛的临床、血液学和性能参数,用含有磺酰胺的三种不同方案进行处理。对14头荷斯坦小牛从出生到60天大进行监测,并将其分为3组。第1组(n=5)动物用80 g Kaopek®(Ibasa,Brazil)口服(BM)处理,每24小时溶于160 ml水中;第2组(n=4)接受IM磺胺嘧啶和甲氧苄啶(Ibatrim®,Ibasa,巴西),第3组(n=5)动物接受80克Kaopek®,Ibisa,巴西,其由16克邻苯二甲酰硫噻唑和2.28克硫酸新霉素、1.6克果胶和80克高岭土组成,溶于160毫升水中,每24小时口服一次,除磺胺嘧啶和甲氧苄啶(Ibatrim®,巴西Ibasa)外,通过IM注射,每日剂量为16 mg/kg活重。在研究过程中,对这些动物进行了临床评估,一旦它们被诊断为腹泻,就收集粪便样本,以鉴定肠道细菌病原体、抗体谱、聚合酶链式反应(PCR)和共寄生虫学检查。采集血液样本以评估血液学特征,并每周监测表现特征。在临床检查中,所有小牛在治疗后体温下降(<39.2°C),水合作用有所改善(p=0,31)。然而,与其他动物相比,第2组的淋巴细胞和TP浓度更好,表现也更好。此外,在100%的粪便样本中检测到大肠杆菌。因此,磺胺类药物用于治疗牛新生儿腹泻的治疗方案对动物的临床改善是有效的。尽管如此,使用磺胺嘧啶和甲氧苄啶(Ibatrim®,Ibasa,巴西)肌肉注射进行全身治疗的方案提供了更好的性能、更好的体重增加和动物的身体发育。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
1.00
自引率
0.00%
发文量
22
审稿时长
47 weeks
期刊介绍: The journal aims to publish full articles, preliminary notes and review articles in the fields of veterinary medicine, animal science and allied sciences, prepared by national and / or foreign, provided that meet the editorial standards
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信